Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.

Noh, Mi Ra; Jang, Hee-Seong; Salem, Fadi E; Ferrer, Fernando A; Kim, Jinu; Padanilam, Babu J

Noh, Mi Ra; Jang, Hee-Seong; Salem, Fadi E; Ferrer, Fernando A; Kim, Jinu; Padanilam, Babu J.

Affiliation

Noh MR; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
Jang HS; Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska.
Salem FE; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
Ferrer FA; Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska.
Kim J; Division of Pediatric Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Padanilam BJ; Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.

Am J Physiol Renal Physiol ; 324(2): F138-F151, 2023 02 01.

Article de En | MEDLINE | ID: mdl-36475868

Sujet(s)
Mots clés

chronic kidney disease; epoxyeicosatrienoic acids; renal fibrogenesis; soluble epoxide hydrolase; unilateral ureteral obstruction

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Obstruction urétérale / Insuffisance rénale chronique Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Am J Physiol Renal Physiol Sujet du journal: FISIOLOGIA / NEFROLOGIA Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google